Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Albuterol nebulizer[1] Salbutamol[1] D02147 [1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 89
2Bramitob® administered by PARI eFlow® rapid electronic nebulizer----[1] 299
3Bramitob® administered by PARI LC® PLUS nebulizer----[1] 299
4Breelib nebulizer----[1] 86
5Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.[1] Amikacin[2] D00865 ,
D02543 		--[1] 299
6Molgramostim 300 µg nebulizer solution[1] Molgramostim[1] D05066 [1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 229
7Molgramostim nebulizer solution[1] Molgramostim[1] D05066 [1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 299
8Nebulizer----[1] 6
9PARI eFlow nebulizer system----[1] 299
10Tobramycin inhalation solution using a PARI LC® Plus nebulizer.[1] Tobramycin[2] D00063 ,
D02542 		--[1] 299
11Treprostinil Ultrasonic Nebulizer[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 85